Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Brainstorm Cell Therapeutics Inc. (BCLI) vs Bolt Biotherapeutics, Inc. (BOLT)

Brainstorm Cell Therapeutics Inc. and Bolt Biotherapeutics, Inc. are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and Bolt Biotherapeutics, Inc. are of similar size ($7.0M and $6.9M). Brainstorm Cell Therapeutics Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 13 metrics below, Brainstorm Cell Therapeutics Inc. leads on 10 and Bolt Biotherapeutics, Inc. on 3.

Valuation

Metric BCLI BOLT Biotechnology median
P/E n/m n/m 7.88
P/S n/m 1.32 11.47
P/B n/m 0.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 1.48 10.73
Earnings yield (97.01%) (447.96%) (28.84%)
Free cash flow yield (38.35%) (496.60%) (23.03%)

Profitability

Metric BCLI BOLT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (654.53%) 0.00%
Net margin 0.00% (611.47%) 0.00%
Free cash flow margin 0.00% (655.72%) 0.00%
Return on equity 119.20% (111.65%) (57.72%)
Return on assets (627.43%) (49.62%) (49.22%)
Return on invested capital 0.00% (143.75%) 0.00%

Growth

Metric BCLI BOLT Biotechnology median
Revenue growth (TTM) — 12.79% 5.64%
EPS growth (last fiscal year) 51.95% 45.91% —
Revenue growth, 5-year CAGR — 101.61% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCLI BOLT Biotechnology median
Debt to equity (0.11) 1.47 0.00
Current ratio 0.03 2.61 4.73
Net debt to EBITDA (0.10) 0.21 0.96

Dividend

Metric BCLI BOLT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCLI BOLT Biotechnology median
Market cap 6.99m 6.92m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack